Please login to the form below

Not currently logged in
Email:
Password:

cancer

This page shows the latest cancer news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca buys FDA priority review voucher from Sobi

AstraZeneca buys FDA priority review voucher from Sobi

However the company suffered a setback yesterday when it announced another failure of Imfinzi in combination with tremelimumab in first-line non-small cell lung cancer.

Latest news

More from news
Approximately 633 fully matching, plus 2,861 partially matching documents found.

Latest Intelligence

  • AI is transforming pharma R&D – now it can transform pharma marketing AI is transforming pharma R&D – now it can transform pharma marketing

    In May 2019, Google reported that its AI could detect early signs of lung cancer in CT scans, in some cases identifying cancers missed by trained oncologists. ... A successful colonoscopy may prevent a cancer being missed, so Ava might help save lives!

  • The evolution of real-world studies The evolution of real-world studies

    Pfizer and the FDA shed light on the evolution of RWE in April when breast cancer drug Ibrance secured approval in a new indication on the strength of data from electronic ... The RWE-focused strategy enabled Pfizer to work round the rarity of male

  • The Cystic Fibrosis Buyers’ Club The Cystic Fibrosis Buyers’ Club

    This includes overriding pharma patents – something the group is advocating in relation to three drugs – Vertex’s cystic fibrosis treatment Orkambi, Pfizer’s breast cancer treatment Ibrance and Roche’s breast ... cancer drug Perjeta.

  • Building Europe’s next breakthrough biotechs Building Europe’s next breakthrough biotechs

    life sciences campus in central Cambridge where AstraZeneca, Cancer Research UK and other leading research organisations are based.

  • Biotech profile: Tom Evans, CEO, Vaccitech.

    You have a broad pipeline of candidates, including therapeutic vaccines, such as your vaccine for prostate cancer in phase 1. ... How big a role do you think therapeutic vaccines will play in future cancer treatment?

More from intelligence
Approximately 8 fully matching, plus 275 partially matching documents found.

Latest appointments

More from appointments
Approximately 5 fully matching, plus 203 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 38 fully matching, plus 178 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics